AMBIT BIOSCIENCES CORP

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$59.4M

154 transactions

Summary

AMBIT BIOSCIENCES CORP is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $20.8MSales: —20 insiders

Date	Insider	Type	Value
2014-11-10	Marchington Allan P	D	$6.5M
2014-11-10	Marchington Allan P	D	$4.6M
2014-11-10	Marchington Allan P	D	$4.6M
2014-11-10	Marchington Allan P	D	$4.2M
2014-11-10	MARTINO MICHAEL A(Chief Executive Officer)	D	$4.1M
2014-11-10	MARTINO MICHAEL A(Chief Executive Officer)	D	$3.8M
2014-11-10	Marchington Allan P	D	$2.2M
2014-11-10	Marchington Allan P	D	$1.0M
2014-11-10	North Annette(Senior VP and General Counsel)	D	$953K
2014-11-10	Countouriotis Athena(Chief Medical Officer)	D	$906K
2014-11-10	MARTINO MICHAEL A(Chief Executive Officer)	D	$385K
2014-11-10	Countouriotis Athena(Chief Medical Officer)	D	$283K
2014-11-10	Countouriotis Athena(Chief Medical Officer)	D	$244K
2014-11-10	North Annette(Senior VP and General Counsel)	D	$211K
2014-11-10	Countouriotis Athena(Chief Medical Officer)	D	$189K
2014-11-10	North Annette(Senior VP and General Counsel)	D	$168K
2014-11-10	MARTINO MICHAEL A(Chief Executive Officer)	D	$147K
2014-11-10	Marchington Allan P	D	$69K
2014-11-10	Marchington Allan P	D	$59K
2014-11-10	FOLETTA MARK G	D	$55K

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

AMBIT BIOSCIENCES CORP — Contributions, Lobbying & Contracts | Poliscope